Inactive Instrument

News MEDH ACQU

Equities

MTAC

US58507N1054

Summary

Unlock all the news: Be the first to know and act before the market!

MEDH ACQU : STANDBY EQUITY PURCHASE AGREEMENT - Form 8-K	03/10/23	PU
MedTech Acquisition, TriSalus Life Sciences Complete Merger	10/08/23	MT
MedTech Acquisition Corporation(NasdaqCM:MTAC) dropped from NASDAQ Composite Index	10/08/23	CI
Trisalus Life Sciences Inc. completed the acquisition of MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others.	09/08/23	CI
Top Premarket Gainers	08/08/23	MT
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders	02/08/23	BU
MedTech Acquisition : Material Event - Form 8-K	02/08/23	PU
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/08/23	CI
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	15/06/23	AQ
MedTech Acquisition Corporation announced that it has received $0.137375 million in funding	14/06/23	CI
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD Method with the TriNav Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting	13/06/23	AQ
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting	12/06/23	BU
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases At the Asco 2023 Annual Meeting	12/06/23	CI
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	08/06/23	AQ
MedTech Acquisition Corporation announced that it expects to receive $17.85502 million in funding	06/06/23	CI
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD Method in Stage IV Uveal Melanoma Patients with Liver Metastases	21/04/23	AQ
MEDTECH ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20/04/23	AQ
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases	20/04/23	BU
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	05/04/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MEDH ACQU

Equities

MTAC

US58507N1054

Summary

Filters